Market research
HTL.V Hamilton Thorne Ltd
V CAD Healthcare
Latest close
As of 29 Dec 2024
Test a moving-average rule with historical data.
Market facts
- Market cap
- 213M
- P/E ratio
- 48.33
- Analyst target
- 2.37
- Dividend yield
- 0.0%
- Beta
- 0.54
Profile
Instrument facts
- Exchange
- V
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- CA4078911001
- Market cap
- 213M
- P/E ratio
- 48.33
- Analyst target
- 2.37
- Dividend yield
- 0.0%
- Beta
- 0.54
About
About Hamilton Thorne Ltd
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services. In addition, it manufactures and distributes products for reproductive medicine, including clinical and laboratory equipment and disposables, as well as complete installations of ART clinics; and bench top incubators, programmable freezers, loggers, alarms, cryo storage, and software systems and sensors for the safe preservation of medical and biological specimens used in ART and cell biology applications. Further, the company offers Cell-Tek Microscope Chamber, a product for controlling temperature, air flow, humidification, and air quality; laminar flow workstations, incubators, and related products; and artificial intelligence enabled CASA software, consumables, and image analysis systems for the ART and laboratory markets, as well as acts as a value-added reseller of a range of capital equipment and consumables. It sells its products and services through a direct sales force in the United States, Germany, France, Australia, Denmark, Spain, and the United Kingdom, as well as through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 75 countries. The company is headquartered in Beverly, Massachusetts.
Research context
Hamilton Thorne Ltd appears in PyInvesting’s TSX Venture Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the HTL.V discussion.
5 years, 6 months ago
Hamilton Thorne Ltd is currently in a long term uptrend where the price is trading 25.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.0.
Hamilton Thorne Ltd's total revenue rose by 10.4% to $10M since the same quarter in the previous year.
Its net income has increased by 40.6% to $459K since the same quarter in the previous year.
Finally, its free cash flow grew by 493.7% to $2M since the same quarter in the previous year.
Based on the above factors, Hamilton Thorne Ltd gets an overall score of 5/5.